Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Degregori

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Oncogene|July 4, 2012
Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?J DeGregori
Dental Survey|May 1, 1970
Words of caution on use of drugsG J DeGregori
Dental Images|January 1, 1971
Drug induced agranulocytosis: report of a caseD F Prico, G J DeGregori
Proceedings of the National Academy of Sciences of the United States of America|December 19, 1995
Regulation of the cyclin E gene by transcription factor E2F1K Ohtani, J DeGregori, J R Nevins
Journal of Lipid Research|May 23, 2001
Construction of stable coxsackievirus and adenovirus receptor-expressing 3T3-L1 cellsD J Orlicky, J DeGregori, J Schaack
Molecular and Cellular Biology|August 1, 1995
Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genesJ DeGregori, T Kowalik, J R Nevins
Leukemia|February 19, 2011
Relative fitness of hematopoietic progenitors influences leukemia progressionC C Porter, D Baturin, R Choudhary, et al.
Molecular Cell|March 17, 1999
Ras enhances Myc protein stabilityR Sears, G Leone, J DeGregori, et al.
Journal of Cellular Physiology|November 20, 1997
Role of the Rb/E2F pathway in cell growth controlJ R Nevins, G Leone, J DeGregori, et al.
Methods in Enzymology|January 1, 1997
Functional analysis of E2F transcription factorJ R Nevins, J DeGregori, L Jakoi, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Oncogene|July 4, 2012
Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?J DeGregori
Dental Survey|May 1, 1970
Words of caution on use of drugsG J DeGregori
Dental Images|January 1, 1971
Drug induced agranulocytosis: report of a caseD F Prico, G J DeGregori
Proceedings of the National Academy of Sciences of the United States of America|December 19, 1995
Regulation of the cyclin E gene by transcription factor E2F1K Ohtani, J DeGregori, J R Nevins
Journal of Lipid Research|May 23, 2001
Construction of stable coxsackievirus and adenovirus receptor-expressing 3T3-L1 cellsD J Orlicky, J DeGregori, J Schaack
Molecular and Cellular Biology|August 1, 1995
Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genesJ DeGregori, T Kowalik, J R Nevins
Leukemia|February 19, 2011
Relative fitness of hematopoietic progenitors influences leukemia progressionC C Porter, D Baturin, R Choudhary, et al.
Molecular Cell|March 17, 1999
Ras enhances Myc protein stabilityR Sears, G Leone, J DeGregori, et al.
Journal of Cellular Physiology|November 20, 1997
Role of the Rb/E2F pathway in cell growth controlJ R Nevins, G Leone, J DeGregori, et al.
Methods in Enzymology|January 1, 1997
Functional analysis of E2F transcription factorJ R Nevins, J DeGregori, L Jakoi, et al.
Pageof 4